Extracellular metabolisation of NADH by blood cells correlates with intracellular ATP levels

Biochimica et Biophysica Acta - General Subjects

Volumn 1573, Issue 2, 2002, Pages 177-182

  Nadlinger, Karl ^a   Westerthaler, Wilhelm ^a   Storga Tomic, Danijela ^a   Birkmayer, J G D ^a   Birkmayer, Jörg G D ^a  

^a Birkmayer Laboratories   (Austria)

Author keywords

ATP; Blood test; NADH; Sports

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

AEROBIC METABOLISM; ARTICLE; BLOOD CELL; CELL ASSAY; CELL ENERGY; CELL LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; FITNESS; HUMAN; HUMAN CELL; METABOLISM; NORMAL HUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; SENSITIVITY ANALYSIS; TRAINING;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BLOOD CELLS; EXERCISE; HUMANS; HYDROGEN-ION CONCENTRATION; METHODS; NAD; REPRODUCIBILITY OF RESULTS; SPECIMEN HANDLING;

EID: 0037078930     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(02)00421-X     Document Type: Article

References (15)

1. Alberts B., Bray D., Lewis J., Raff H., Roberts K., Watson J.D. Energy Conversion: Mitochondria and Chloroplasts in Molecular Biology of the Cell. 3rd ed. 1994;653-720 Garland Publishing, New York.
2. A.L. Lehninger, Vitamins and Coenzymes in Biochemistry, 2nd ed., the John Hopkins University School of Medicine, Worth Publishers, New York, 1975, pp. 337-342.
3. Cooper J.M., Mann V.N., Krige D., Schapira A.H.V. Human mitochondrial complex I dysfunction. Biochim. Biophys. Acta. 1101:1992;198-203.
4. Mizuno Y., Otha S., Tanaka M., Takamiya S., Suzuki K., Oya H., Ozamwa T., Kagawa Y. Deficiencies in complex I subunits of the respiratory chain in Parkinson's Disease. Biochem. Biophys. Res. Commun. 163:1989;1450-1455.
5. Shoffner J.M., Wafts R.L., Juncos J.L., Torroni A., Wallace D.C. Mitochondrial oxidative phosphorylation defects in Parkinson's Disease. Ann. Neurol. 30:1991;332-339.
6. Bennecke R., Strumper P., Weiss H. Electron transfer complex I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. Brain. 116:1993;1451-1463.
7. Dalakas M.C., Lila I., Pezeshkpour G.H., Laukaftis J.P., Cohen B., Griffin J.L. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322:1990;1098-1105.
8. Birkmayer W., Birkmayer J.G.D., Vrecko C., Paletta B., Reschenhofer E., Ott E. NADH bei Parkinson. New Trends Clin. Neuropharm. 4:1990;7-24.
9. Birkmayer J.G.D. NADH bei Alzheimer. Ann. Clin. Lab. Sci. 26:1996;1-8.
10. Forsyth L.M., Preuss H.G., MacDowell A.L., Chiazze L., Birkmayer J.G.D., Bellanti J.A. Therapeutic effects of oral NADH on the symptoms of patients with chronic fatigue syndrome. Ann. Allergy, Asthma, & Immun. 82:1999;185-191.
11. Haten Y., Stiggall D.L. Preparation and properties of NADH cytochrome c oxidoreductase (complex III). Fleischer S., Packer L. Methods in Enzymology. 1978;5-10 Academic Press, New York.
12. Formato M., Masala B., De Luca G. The levels of adenine nucleotides and pyridine coenzymes in red blood cells from the newborn, determined simultaneously by HPLC. Clin. Chim. Acta. 189:1990;131-138.
13. Stocchi V., Cucchiarini L., Magnani M., Chiarantini L., Palma P., Crescentini G. Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells. Anal. Biochem. 146:1985;118-124.
14. Leoncini G., Buzzi E., Maresca M., Mazzei M., Balbi A. Alkaline extraction and reverse-phase high-performance liquid chromatography of adenine and pyridine nucleotides in human platelets. Anal. Biochem. 165:1987;379-383.
15. Nelson D.L., Cox M.M. Principles of bioenergetics. Lehninger A.L. Principles of Biochemistry. 3rd ed. 2000;501-502 Worth Publishers, New York.